| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
LONDON, Ontario—Plant-made pharmaceutical production has been studied extensively over the past few decades, but the ability to transmit therapeutics through the ingestion of these same plants is less well understood. Recently, researchers at Agriculture Canada, Plantigen and several academic centers examined the use of low-alkaloid tobacco as a delivery vehicle for anti-inflammatory cytokines in a mouse model of inflammatory bowel disease (IBD).
 
As they reported in the Plant Biotechnology Journal, the researchers developed a transgenic strain of tobacco that both expressed human IL-10, a cytokine used to ameliorate inflammation, and exhibited diminished levels of alkaloids like nicotine. They then fed tobacco-laced chow to mice and looked at how well the mice tolerated the tobacco product and its impact on inflammatory response.
 
The researchers found that the low-alkaloid tobacco had no impact on general mouse viability. They also noted that not only did the recombinant IL-10 survive transit through the digestive tract, but it triggered decrease expression of TNF-α, an inflammatory cytokine, and generally improved gut histology.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

GreenCooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue